Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, cognitive decline, and changes in behavior, significantly impacting daily life.
Fasudil for Early Alzheimer's Disease
We are studying whether fasudil can help prevent memory loss in people with early Alzheimer's disease. The trial will also assess its safety and effects on brain health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Cognitive Impairment
Cognitive impairment refers to a decline in cognitive function, affecting memory, thinking, and reasoning skills, which can interfere with daily activities.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 50 years old or older?
- Do you have a diagnosis of mild Alzheimer's disease (mild AD dementia) or mild cognitive impairment (MCI)?
- Are you currently taking any medications for depression or dementia, like Donepezil or Memantine?
- Are you pregnant or breastfeeding, or do you have a negative pregnancy test within the last 14 days?
- Do you have any current significant mental health issues that might affect your ability to participate?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Fasudil
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Haraldsplass Diakonale Sykehus AS
Internal Medicine
Bergen, Norway
Helse Fonna HF
Age Related Medicine
Haugesund, Norway
Helse Stavanger HF
Centre for Age-Related Medicine
Stavanger, Norway
Sponsor: Helse Stavanger HF
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.